首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5092篇
  免费   243篇
  国内免费   5篇
电工技术   40篇
综合类   3篇
化学工业   1435篇
金属工艺   61篇
机械仪表   87篇
建筑科学   192篇
矿业工程   8篇
能源动力   187篇
轻工业   811篇
水利工程   56篇
石油天然气   22篇
无线电   373篇
一般工业技术   731篇
冶金工业   294篇
原子能技术   13篇
自动化技术   1027篇
  2024年   5篇
  2023年   56篇
  2022年   166篇
  2021年   219篇
  2020年   149篇
  2019年   158篇
  2018年   166篇
  2017年   139篇
  2016年   190篇
  2015年   143篇
  2014年   210篇
  2013年   420篇
  2012年   346篇
  2011年   464篇
  2010年   267篇
  2009年   273篇
  2008年   267篇
  2007年   250篇
  2006年   205篇
  2005年   136篇
  2004年   152篇
  2003年   126篇
  2002年   114篇
  2001年   62篇
  2000年   58篇
  1999年   76篇
  1998年   85篇
  1997年   63篇
  1996年   52篇
  1995年   50篇
  1994年   37篇
  1993年   36篇
  1992年   21篇
  1991年   17篇
  1990年   23篇
  1989年   9篇
  1988年   11篇
  1987年   15篇
  1986年   12篇
  1985年   12篇
  1984年   3篇
  1983年   10篇
  1982年   8篇
  1981年   7篇
  1980年   9篇
  1977年   4篇
  1976年   12篇
  1975年   3篇
  1973年   4篇
  1967年   4篇
排序方式: 共有5340条查询结果,搜索用时 15 毫秒
61.
PURPOSE: To assess the "in vivo" effect of 13-cis-retinoic acid and low dose Ara-C in MDS as well as to establish "in vitro" advantage of retinoid dose-related growth pattern on bone marrow cultures as defined by culture timing and CFU-GM proliferative response. PATIENTS AND METHODS: We evaluated 28 patients diagnosed of MDS according to FAB classification, of whom 4 cases had RA, 8 cases SRA, 14 cases RAEB and 2 cases RAEB-T. Patients who had RA and SRA were treated with oral 13-cis-retinoic acid at doses of 20-40 mg daily for 4 months and those cases with RAEB and RAEB-T had subcutaneous Ara-C at doses of 3 mg/m2 twice a day for 21 days. The "in vivo" and "in vitro" effect of retinoic acid on the haemopoietic differentiation was evaluated by the growth CFU-GM in semisolid cell culture methods. RESULTS: Increasing in vitro concentrations of 13-cis retinoic acid did not enhance the growth of myelodysplastic progenitors. Nevertheless, our study did not find any beneficial therapeutic effect of retinoic compounds in MDS patients. In this study, low-dose Ara-C (3 mg/m2) showed similar effects when compared with higher doses reported by others. Furthermore, in terms of CFU-GM proliferation the concentration of colonies before and after treatment were fairly similar in all but two patients. CONCLUSIONS: The results drawn from our study demonstrated that there is no beneficial advantage of 13-cis-retinoic acid as a differentiation inducing agent on myelodysplastic patients. In contrast, lower doses of Ara-C showed similar effects on haemopoiesis of MDS patients than standard doses of 10-20 mg/m2 but with less side effects.  相似文献   
62.
Magnetic Resonance Materials in Physics, Biology and Medicine - Histogram-based metrics extracted from diffusion-tensor imaging (DTI) have been suggested as potential biomarkers for cerebral small...  相似文献   
63.
Software Quality Journal - The number of electronic control units (ECU) installed in vehicles is increasingly high. Manufacturers must improve the software quality and reduce cost by proposing...  相似文献   
64.
We investigate the dynamics of granular flows under the action of a centrifugal acceleration field. The granular flows consist of a monodisperse set of glass beads flowing down an inclined plane. The experiments are performed at variable slope angles \(\zeta \) and equivalent centrifugal accelerations \(a_\text {cf}\equiv Ng\). We study the effect of this parameters on the superficial flow velocity u and flow height h. Two trends are observed, by increasing \(\zeta \) and \(a_\text {cf}\), u increases proportionally, and h decreases asymptotically until a constant height. This relation is analysed in terms of the system potential and kinetic energy, leading to the estimation of equivalent impact forces one order of magnitude larger than those observed in small scale 1g laboratory experiments, with the possibility to reach higher forces by increasing N. Finally, considering the trend of u and h, our results suggest a scaling principle of inertial velocity proportional to \(\sqrt{N}\).  相似文献   
65.
When interval-grouped data are available, the classical Parzen–Rosenblatt kernel density estimator has to be modified to get a computable and useful approach in this context. The new nonparametric grouped data estimator needs of the choice of a smoothing parameter. In this paper, two different bandwidth selectors for this estimator are analyzed. A plug-in bandwidth selector is proposed and its relative rate of convergence obtained. Additionally, a bootstrap algorithm to select the bandwidth in this framework is designed. This method is easy to implement and does not require Monte Carlo. Both proposals are compared through simulations in different scenarios. It is observed that when the sample size is medium or large and grouping is not heavy, both bandwidth selection methods have a similar and good performance. However, when the sample size is large and under heavy grouping scenarios, the bootstrap bandwidth selector leads to better results.  相似文献   
66.
67.
The use of colloidal quantum dots (CQDs) as a gain medium in infrared laser devices has been underpinned by the need for high pumping intensities, very short gain lifetimes, and low gain coefficients. Here, PbS/PbSSe core/alloyed-shell CQDs are employed as an infrared gain medium that results in highly suppressed Auger recombination with a lifetime of 485 ps, lowering the amplified spontaneous emission (ASE) threshold down to 300 µJ cm−2, and showing a record high net modal gain coefficient of 2180 cm−1. By doping these engineered core/shell CQDs up to nearly filling the first excited state, a significant reduction of optical gain threshold is demonstrated, measured by transient absorption, to an average-exciton population-per-dot 〈Nthg of 0.45 due to bleaching of the ground state absorption. This in turn have led to a fivefold reduction in ASE threshold at 〈NthASE = 0.70 excitons-per-dot, associated with a gain lifetime of 280 ps. Finally, these heterostructured QDs are used to achieve near-infrared lasing at 1670 nm at a pump fluences corresponding to sub-single-exciton-per-dot threshold (〈NthLas = 0.87). This work brings infrared CQD lasing thresholds on par to their visible counterparts, and paves the way toward solution-processed infrared laser diodes.  相似文献   
68.
69.
International Journal of Control, Automation and Systems - This paper presents a Non-Uniform Predictor-Observer (NUPO) based control approach in order to deal with two of the main problems related...  相似文献   
70.
Diabetes therapy management in AAL environments, such as old people and diabetes patients homes, is a very difficult task since many factors affect a patient’s blood sugar levels. Factors such as illness, treatments, physical and psychological stress, physical activity, drugs, intravenous fluids and change in the meal plan cause unpredictable and potentially dangerous fluctuations in blood sugar levels. Right now, operations related to dosage are based on insulin infusion protocol boards, which are provided by physicians to the patients. These boards are not considering very influential factors such as glycemic index from the diet, consequently patients need to estimate the dosage leading to dose error, which culminates in hyperglycemia and hypoglycemia episode. Therefore, right insulin infusion calculation needs to be supported by the next generation of personal-care devices. For this reason, a personal device has been developed to assist and consider more factors in the insulin therapy dosage calculation. The proposed solution is based on Internet of things in order to, on the one hand, support a patient’s profile management architecture based on personal RFID cards and, on the other hand, provide global connectivity between the developed patient’s personal device based on 6LoWPAN, nurses/physicians desktop application to manage personal health cards, glycemic index information system, and patient’s web portal. This solution has been evaluated by a multidisciplinary group formed by patients, physicians, and nurses.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号